In contrast, the expression of BMPR1A was significantly higher in stage 4 than in stage 1 NB, and was also higher in MYCN-amplified than non-MYCN-amplified NB, implying that this BMP receptor plays an opposing role to that of BMPR1B and BMPR2 on NB cell fate. This evidence concerns the gene BMPR1A and neuroblastoma.